Euclidean Capital's book
22 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| ArsenalBio | — | $1.9B | — | — | |
| Neurona Therapeutics | Drug Discovery | $1.1B | — | — | |
| Neo Alternative Asset Managers | — | $1.1B | — | — | |
| SetPoint Medical | Therapeutic Devices | $480.0M | — | — | |
| Zeitview | — | $443.9M | — | — | |
| Sion Power | — | $435.0M | — | — | |
| FundGuard | — | $390.0M | — | — | |
| Ripple (Berkeley) | — | $357.3M | — | — | |
| A2 Bio | — | $280.0M | — | — | |
| Circle Pharma | — | $269.0M | — | — | |
| + 12 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 22 recorded positions
- ·Watchlist + alerts for Euclidean Capital's activity
Create free account
No card required